Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Int J Cardiol ; 191: 286-93, 2015 Jul 15.
Article in English | MEDLINE | ID: mdl-25981371

ABSTRACT

BACKGROUND: In chronic heart failure, left ventricular ejection fraction (LVEF) is considered to be stable. Intensified therapy may improve survival, but little is known whether this is associated with reverse remodeling and dependent on age and NT-proBNP guidance. We aimed to define the evolution of LVEF under intensified therapy in relation to age and NT-proBNP guidance. METHODS AND RESULTS: Echocardiography was performed at baseline, 12 and 18months in TIME-CHF, a trial comparing NT-proBNP versus symptom-guided therapy in patients aged 60 to 74 and ≥75 years. LVEF, LV end diastolic volume index (LVEDVI) and end systolic volume index (LVESVI) were assessed. LVEF increased from 31.3 ± 10.7% to 39.1±11.8% at 18 months (p<0.001) in symptom-guided, and from 30.3 ± 11.7% to 44.0 ± 13.2% (p<0.001) in NT-proBNP-guided patients. The increase in LVEF was significantly larger in the NT-proBNP-guided treatment group (p for interaction=0.006), which was true for both age groups (p for interaction in both=0.091). LVEDVI and LVESVI decreased without influence by study group allocation. CONCLUSIONS: In elderly heart failure patients, intensified medical therapy leads to an improvement in LVEF and to reverse remodeling. NT-proBNP guided therapy was associated with a larger improvement in LVEF than symptom guided therapy both in patients aged 60 to 74 and ≥75 years. TRIAL REGISTRATION: http://isrctn.org Identifier: ISRCTN43596477.


Subject(s)
Heart Failure/diagnostic imaging , Heart Failure/drug therapy , Natriuretic Peptide, Brain/therapeutic use , Peptide Fragments/therapeutic use , Stroke Volume , Ventricular Remodeling , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective Studies , Single-Blind Method , Stroke Volume/physiology , Ultrasonography , Ventricular Remodeling/physiology
2.
J Card Fail ; 20(2): 98-104, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24361805

ABSTRACT

BACKGROUND: Pulmonary hypertension due to left heart disease is very common. Our aim was to investigate the relationship of the severity of left ventricular diastolic dysfunction with precapillary and postcapillary pulmonary hypertension (PH) in an elderly heart failure (HF) population. METHODS AND RESULTS: A post hoc analysis of the Trial of Intensified Medical Therapy in Elderly Patients With Congestive Heart Failure data was done. Baseline transthoracic echocardiography was used to categorize diastolic function, estimate pulmonary artery pressure and pulmonary capillary wedge pressure, and calculate the transpulmonary pressure gradient (TPG). Among 392 HF patients, PH was present in 31% of patients with grade 1, in 37% of patients with grade 2, and in 65% of patients with grade 3 diastolic dysfunction; 54% of all HF patients with PH had a TPG >12 mm Hg, suggesting not only a postcapillary but also an additional precapillary component of PH. Survival was not related to the severity of diastolic dysfunction, but was worse in patients with PH (hazard ratio 1.63, 95% confidence interval 1.07-2.51; P = .024). CONCLUSIONS: Our data indicate that HF patients with even mild diastolic dysfunction often have PH. Echocardiographic assessment suggest that the presence of PH might not simply be due to increased PCWP, but in part due to a precapillary component.


Subject(s)
Heart Failure/diagnostic imaging , Heart Failure/epidemiology , Hypertension, Pulmonary/diagnostic imaging , Hypertension, Pulmonary/epidemiology , Population Surveillance , Aged , Aged, 80 and over , Blood Pressure/physiology , Diastole , Female , Follow-Up Studies , Heart Failure/physiopathology , Humans , Hypertension, Pulmonary/physiopathology , Male , Prospective Studies , Ultrasonography
3.
Int J Cardiovasc Imaging ; 29(3): 581-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22965859

ABSTRACT

We aimed to study the potential influence of the variability in the assessment of echocardiographically measured left ventricular ejection fraction (LVEF) on indications for the implantation of internal cardioverter defibrillator and/or cardiac resynchronization devices in heart failure patients. TIME-CHF was a multicenter trial comparing NT-BNP versus symptom-guided therapy in patients aged ≥60 years. Patients had their LVEF assessed at the recruiting centre using visual assessment, the area-length or biplane Simpson's method. Echocardiographic data were transferred to the study core-lab for re-assessment. Re-assessment in the core-lab was done with biplane Simpson's method, and included an appraisal of image quality. 413 patients had the LVEF analyzed at the recruiting centre and at the core lab. Image quality was optimal in 191 and suboptimal in 222. Overall, the correlation between LVEF at the recruiting centres and at the core-lab was good, independent of image quality (R² = 0.62). However, when a LVEF ≤30 % or ≥30 % was used as a cut-off, about 20 % of all patients would have been re-assigned to having either a LVEF above or below the cut-off, this proportion was not significantly influenced by image quality. We conclude that correlation between LVEF assessed by different centres based on the same ultrasound data is good, regardless of image quality. However, one fifth of patients would have been re-assigned to a different category when using the clinically important cut-off of 30 %.


Subject(s)
Decision Support Techniques , Heart Failure/diagnostic imaging , Heart Failure/physiopathology , Stroke Volume , Ventricular Function, Left , Aged , Aged, 80 and over , Biomarkers/blood , Cardiac Resynchronization Therapy , Cardiac Resynchronization Therapy Devices , Defibrillators, Implantable , Electric Countershock/instrumentation , Germany , Heart Failure/blood , Heart Failure/therapy , Humans , Image Interpretation, Computer-Assisted , Linear Models , Natriuretic Peptide, Brain/blood , Observer Variation , Patient Selection , Peptide Fragments/blood , Predictive Value of Tests , Prognosis , Reproducibility of Results , Switzerland , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...